Supernus Pharmaceuticals, Inc. SUPN

US Pharmaceuticals

$27.62 ▲ +5.58% (+$1.46)

Open $27.05

Prev Close $26.16

Day Range $26.11 – $27.91

52W Range $25.92 – $59.68

Market Cap $5.43B

P/E (TTM) 15.80

Beta 0.66

EPS (TTM) $2.73

📋 Company Profile

Industry	Pharmaceuticals
Country	US
Exchange	NASDAQ NMS - GLOBAL MARKET
Currency	USD
IPO Date	2010-12-28
Shares Out.	58,240,000
Website	supernus.com ↗
Phone	13018382500
Employees	778

About Supernus Pharmaceuticals, Inc.

Supernus Inc is a diversified biopharmaceutical company focused on developing and commercializing treatments for patients living with central nervous system (CNS) diseases. The company's commercial portfolio includes approved treatments designed to support individuals navigating opioid use disorder (OUD), attention-deficit hyperactivity disorder (ADHD), dyskinesia in Parkinson's disease (PD) for those receiving levodopa-based therapy, hypomobility in PD, postpartum depression (PPD), epilepsy, migraine, cervical dystonia, and chronic sialorrhea.

Supernus Pharmaceuticals, Inc. is a publicly traded company under the ticker symbol SUPN on the NASDAQ NMS - GLOBAL MARKET, operating in the Pharmaceuticals industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.